|
Sign In to gain access to subscriptions and/or personal tools.
|
Bleeding After Circumcision in a Newborn Receiving Sildenafil
David Gamboa, MD
Children's Hospital & Research Center, Oakland, Calfornia, dgamboa{at}mail.cho.org
Daniel Robbins, MD
Lamorinda Pediatrics, Lafayette, California
Ziad Saba, MD
Department of Cardiology, Children's Hospital & Research Center, Oakland, California
This report describes a case of bleeding as a complication of circumcision in a 2-week-old infant being treated with sildenafil for persistent pulmonary hypertension of the newborn. The vasodilatory effects of sildenafil on the penile vasculature may have contributed to the postoperative bleeding in this patient.
Key Words: persistent pulmonary hypertension of the newborn sildenafil pulmonary vascular resistance phosphodiesterase type 5 circumcision
References
- Lakshminrusimha S., Steinhorn RH Pulmonary vascular biology during neonatal transition. Clin Perinatol. 1999;26:601-619.[Web of Science][Medline]
[Order article via Infotrieve]
- Fox WW, Gewitz MG, Sinwiddie R., et al. Pulmonary hypertension in the perinatal aspiration syndromes. Pediatrics. 1977;59:205-211.[Abstract/Free Full Text]
- Konduri GG New approaches for persistent pulmonary hypertension of the newborn. Clin Perinatol. 2004;31: 591-611.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Walsh-Sukys MC, Tyson JE, Wright LL, et al. Persistent pulmonary hypertension of the newborn in the era before nitric oxide: practice variation and outcomes. Pediatrics. 2000;105:14-20.[Abstract/Free Full Text]
- The Neonatal Inhaled Nitric Oxide Study Group. Inhaled nitric oxide in full-term and nearly full-term infants with hypoxic respiratory failure. N Engl J Med. 1997;336:597-604.[Abstract/Free Full Text]
- Shekerdemian LS, Ravn HB, Penny DJ Intravenous sildenafil lowers pulmonary vascular resistance in a model of neonatal pulmonary hypertension. Am J Respir Crit Care Med. 2002;165:1098-1102.[Abstract/Free Full Text]
- Sastry BK, Narasimhan C., Reddy NK, Raju BS Clinical efficacy of sildenafil in primary pulmonary hypertension: A randomized, placebo-controlled, double-blind, crossover study. J Am Coll Cardiol. 2004;43:1149-1532.[Abstract/Free Full Text]
- Michelakis E., Tymchak W., Lien D., et al. Oral Sildenafil is an effective and specific pulmonary vasodilator in patients with pulmonary arterial hypertension: Comparison with inhaled nitric oxide. Circulation. 2002;105:2398-2403.[Abstract/Free Full Text]
- Turko IV, Ballard SA, Francis SH, Corbin JD Inhibition of cyclic GMP-binding cyclic GMP-specific phosphodiesterase (type 5) by sildenafil and related compounds. Mol Pharmacol. 1999;56:124-130.[Abstract/Free Full Text]
- Michelakis E., Tymchak W., Archer S. Sildenafil: From the bench to the bedside. CMAJ. 2000;163:1171-1175.[Abstract/Free Full Text]
- Abrams D., Schulze-Neick I., Magee AG Sildenafil as a selective pulmonary vasodilator in childhood primary pulmonary hypertension. Heart. 2000;84:e4.[CrossRef][Medline]
[Order article via Infotrieve]
- Carroll WD, Dhillon R. Sildenafil as a treatment for pulmonary hypertension. Arch Dis Child. 2003;88: 827-828.[Abstract/Free Full Text]
- Baquero H., Soliz A., Neira F., et al. Oral sildenafil in infants with persistent pulmonary hypertension of the newborn: A pilot randomized blinded study. Pediatrics. 2006;117:1077-1083.[Abstract/Free Full Text]
This version was published on December
1, 2007
Clinical Pediatrics, Vol. 46, No. 9,
842-843 (2007)
DOI: 10.1177/0009922807303546

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati Twitter What's this?
|
|